Adamis pharma provides regulatory update for higher dose naloxone pre-filled syringe

Adamis pharmaceuticals provides regulatory update for its higher dose naloxone pre-filled syringe.adamis pharmaceuticals - co has not received any notice of action from u.s fda on company's new drug application relating to its zimhi.adamis pharmaceuticals - intends to make an announcement relating to fda action concerning nda after it receives a notice of action from the agency.
ADMP Ratings Summary
ADMP Quant Ranking